open access

Vol 73, No 1 (2022)
Letter to the Editor
Submitted: 2022-03-22
Accepted: 2022-03-24
Published online: 2022-03-31
Get Citation

Hyperbaric oxygen therapy in necrotizing soft tissue infections caused by Vibrio species from the Baltic Sea — three clinical cases

Jacek Kot1, Ewa Lenkiewicz2
·
Pubmed: 35380174
·
IMH 2022;73(1):52-55.
Affiliations
  1. National Centre for Hyperbaric Medicine, Institute of Maritime and Tropical Medicine in Gdynia, Medical University of Gdansk, Poland
  2. Department of Hyperbaric Medicine and Sea Rescue, University Centre for Maritime and Tropical Medicine in Gdynia, Poland

open access

Vol 73, No 1 (2022)
LETTERS TO THE EDITOR
Submitted: 2022-03-22
Accepted: 2022-03-24
Published online: 2022-03-31

Abstract

Not available

Abstract

Not available
Get Citation
About this article
Title

Hyperbaric oxygen therapy in necrotizing soft tissue infections caused by Vibrio species from the Baltic Sea — three clinical cases

Journal

International Maritime Health

Issue

Vol 73, No 1 (2022)

Article type

Letter to the Editor

Pages

52-55

Published online

2022-03-31

Page views

4989

Article views/downloads

478

DOI

10.5603/IMH.2022.0007

Pubmed

35380174

Bibliographic record

IMH 2022;73(1):52-55.

Authors

Jacek Kot
Ewa Lenkiewicz

References (19)
  1. Kurpas M, Michalska M, Zakrzewski A, et al. First report of the presence of Vibrio vulnificus in the Gulf of Gdansk. Int Marit Health. 2021; 72(4): 247–251.
  2. Huang KC, Weng HH, Yang TY, et al. Distribution of fatal vibrio vulnificus necrotizing skin and soft-tissue infections: a systematic review and meta-analysis. Medicine (Baltimore). 2016; 95(5): e2627.
  3. Baker-Austin C, Trinanes JA, Taylor NGH, et al. Emerging Vibrio risk at high latitudes in response to ocean warming. Nature Climate Change. 2012; 3(1): 73–77.
  4. Morgan MS. Diagnosis and management of necrotising fasciitis: a multiparametric approach. J Hosp Infect. 2010; 75(4): 249–257.
  5. Shiroff AM, Herlitz GN, Gracias VH. Necrotizing soft tissue infections. J Intensive Care Med. 2014; 29(3): 138–144.
  6. Misiakos EP, Bagias G, Patapis P, et al. Current concepts in the management of necrotizing fasciitis. Front Surg. 2014; 1: 36.
  7. Pelletier J, Gottlieb M, Long B, et al. Necrotizing soft tissue infections (NSTI): pearls and pitfalls for the emergency clinician. J Emerg Med. 2022 [Epub ahead of print].
  8. Garcia NM, Cai J. Aggressive soft tissue infections. Surg Clin North Am. 2018; 98(5): 1097–1108.
  9. Elnahla A, Attia AS, Toraih E, et al. Prognostic factors of mortality in sepsis and soft tissue infections: meta-analysis. Surg Infect (Larchmt). 2021; 22(9): 928–939.
  10. Wang J, Corson K, Mader J. Hyperbaric oxygen as adjunctive therapy in Vibrio vulnificus septicemia and cellulitis. Undersea Hyperb Med. 2004; 31(1): 179–181.
  11. Yagi H, Takechi Y, Hiraki S, et al. [A life saving case of Vibrio vulnificus (septic type)]. Kansenshogaku Zasshi. 2003; 77(3): 167–173.
  12. Aksak-Wąs BJ, Ripa A, Szakoła P, et al. Septic shock induced by vibrio vulnificus in northern poland, a case report. Infect Drug Resist. 2021; 14: 5027–5033.
  13. Hedetoft M, Bennett MH, Hyldegaard O. Adjunctive hyperbaric oxygen treatment for necrotising soft-tissue infections: A systematic review and meta-analysis. Diving Hyperb Med. 2021; 51(1): 34–43.
  14. Memar MY, Yekani M, Alizadeh N, et al. Hyperbaric oxygen therapy: Antimicrobial mechanisms and clinical application for infections. Biomed Pharmacother. 2019; 109: 440–447.
  15. Tamura T, Iida Ki, Saito M, et al. Effect of hyperbaric oxygen on Vibrio vulnificus and murine infection caused by it. Microbiol Immunol. 2012; 56(10): 673–679.
  16. Keck PE, Gottlieb SF, Conley J. Interaction of increased pressures of oxygen and sulfonamides on the in vitro and in vivo growth of pathogenic bacteria. Undersea Biomed Res. 1980; 7(2): 95–106.
  17. Gottlieb SF, Pakman LM. Effect of high oxygen tensions on the growth of selected, aerobic, gram-negative, athogenic bacteria. J Bacteriol. 1968; 95(3): 1003–1010.
  18. Mathieu D, Marroni A, Kot J. Tenth European Consensus Conference on Hyperbaric Medicine: recommendations for accepted and non-accepted clinical indications and practice of hyperbaric oxygen treatment. Diving Hyperb Med. 2017; 47(1): 24–32.
  19. Mathieu D, Ratzenhofer-Komenda B, Kot J. Hyperbaric oxygen therapy for intensive care patients: position statement by the European Committee for Hyperbaric Medicine. Diving Hyperb Med. 2015; 45(1): 42–46.

Regulations

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By VM Media Group sp. z o.o., Grupa Via Medica, ul. Świętokrzyska 73, 80–180 Gdańsk, Poland

tel.: +48 58 320 94 94, fax:+48 58 320 94 60, e-mail: viamedica@viamedica.pl